Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000217845 | SCV000268933 | benign | not specified | 2014-11-24 | criteria provided, single submitter | clinical testing | Ser744Thr in exon 6C of DAG1: This variant is not expected to have clinical sign ificance because it has been identified in 3.1% (136/4406) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs114357468). |
Prevention |
RCV000217845 | SCV000306918 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000217845 | SCV000528053 | benign | not specified | 2016-08-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000554129 | SCV000650612 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2P; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000217845 | SCV001475053 | benign | not specified | 2020-02-13 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004715766 | SCV005303503 | benign | not provided | criteria provided, single submitter | not provided |